Skip to main content
Log in

Ergot alkaloids in sclerotia collected in Japan: synthetic profiles and induction of apoptosis by Clavine-type compounds

  • Original Paper
  • Published:
Journal of Natural Medicines Aims and scope Submit manuscript

Abstract

The genus Claviceps (Clavicipitaceae) is famous for producing ergot alkaloids (EAs) in sclerotia. EAs can cause ergotism, resulting in convulsions and necrosis when ingested, making these compounds a serious concern for food safety. Agroclavine (2), a typical Clavine-type EA, is a causative agent of ergotism and is listed as a compound to be monitored by the European Food Safety Authority. Clavine-type EAs are known to cause cytotoxicity, but the mechanism has not been elucidated. We performed annexin V and PI double-staining followed by flow cytometric analysis to detect apoptosis in HepG2 and PANC-1 cells after exposure to Clavine-type EAs. Clavine-type EAs reduced cell viability and induced apoptosis in both cell lines. We then performed LC–MS analysis of EAs from 41 sclerotia samples of Claviceps collected in Japan. 24 out of 41 sclerotia extracts include peptide-type EAs (ergosine/inine: 4/4′, ergotamine: 5, ergocornine/inine: 6/6′, α-ergocryptine/inine: 8/8′, and ergocristine/inine: 9/9′) and 19 sclerotia extracts among 24 sclerotia detected peptide type EAs include Clavine-type EAs (pyroclavine: 1, agroclavine: 2, festuclavine: 3) by LC–MS. We then performed a metabolomic analysis of the EAs in the sclerotia using principal component analysis (PCA). The PCA score plots calculated for EAs suggested the existence of four groups with different EA production patterns. One of the groups was formed by the contribution of Clavine-type EAs. These results suggest that Clavine-type EAs are a family of compounds requiring attention in food safety and livestock production in Japan.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding authors upon reasonable request.

References

  1. Flieger M, Wurst M, Shelby R (1997) Ergot alkaloids - sources, structures and analytical methods. Folia Microbiol (Praha) 42:3–30

    Article  CAS  PubMed  Google Scholar 

  2. Lee MR (2009) The history of ergot of rye (Claviceps purpurea) II: 1900–1940. J R Coll Physicians Edinburgh 39:365–369

    Article  CAS  Google Scholar 

  3. Lee MR (2009) The history of ergot of rye (Claviceps purpurea) I: from antiquity to 1900. J R Coll Physicians Edinb 39:179–184

    CAS  PubMed  Google Scholar 

  4. Buchta M, Cvak L (1999) Ergot alkaloids and other metabolites of the genus Claviceps. Ergot. CRC Press, Florida, pp 188–216

    Google Scholar 

  5. Krishnamachari KA, Bhat RV (1976) Poisoning by ergoty bajra (pearl millet) in man. Indian J Med Res 64:1624–1628

    CAS  PubMed  Google Scholar 

  6. Belser-Ehrlich S, Harper A, Hussey J, Hallock R (2013) Human and cattle ergotism since 1900. Toxicol Ind Health 70:307–316

    Article  Google Scholar 

  7. Urga K, Asfaw D, Yeshi WM, Agata N, Abebe B, Wubalem Z (2002) Laboratory studies on the outbreak of Gangrenous ergotism associated with consumption of contaminated barley in Arsi, Ethiopia. Ethiop J Heal Dev 16:317–323

    Google Scholar 

  8. European food safety Authority (2012) Scientific Opinion on ergot alkaloids in food and feed. EFSA J 10:2798

    Google Scholar 

  9. Takemoto J (1944) [Investigation of “alkaloid” content in domestic and foreign wild ergot (Report 1) qualitative test.] Naigai yasei bakkaku no “alkaloid” ganyu tyousa (dai 1 hou) teisei shiken (in Japanese). Yakugaku Zasshi 64:225–228

    Article  CAS  Google Scholar 

  10. Takemoto J (1944) [Investigation of “alkaloid” content in domestic and foreign wild ergot (Report 2) quantitative test.] Naigai yasei bakkaku no “alkaloid” ganyu tyousa (dai 2 hou) teiryou shiken (in Japanese). Yakugaku Zasshi 64:228–231

    Article  CAS  Google Scholar 

  11. Tanaka K, Sugawa T (1952) Studies on ergot alkaloids by paper partition chromatography I. Yakugaku Zasshi 72:616–620

    Article  CAS  Google Scholar 

  12. Tanaka K, Sugawa T (1952) Studies on ergot alkaloids by paper partition chromatography II. Yakugaku Zasshi 72:620–623

    Article  CAS  Google Scholar 

  13. Doi Y, Wakana D, Takeda H, Tanaka E, Hosoe T (2022) Production of ergot alkaloids by the Japanese isolate Claviceps purpurea var. agropyri on rice medium. Adv Microbiol 12:254–269

    Article  CAS  Google Scholar 

  14. Mulac D, Lepski S, Ebert F, Schwerdtle T, Humpf HU (2013) Cytotoxicity and fluorescence visualization of ergot alkaloids in human cell lines. J Agric Food Chem 61:462–471

    Article  CAS  PubMed  Google Scholar 

  15. Mrusek M, Seo EJ, Greten HJ, Simon M, Efferth T (2015) Identification of cellular and molecular factors determining the response of cancer cells to six ergot alkaloids. Invest New Drugs 33:32–44

    Article  CAS  PubMed  Google Scholar 

  16. Hothorn T, Bretz F, Westfall P (2008) Simultaneous inference in general parametric models. Biometrical J 50:346–363

    Article  Google Scholar 

  17. Píchová K, Pažoutová S, Kostovčík M, Chudíčková M, Stodůlková E, Novák P, Flieger M, Linde E, Kolařík M (2018) Evolutionary history of ergot with a new infrageneric classification (Hypocreales: Clavicipitaceae: Claviceps). Mol Phylogenet Evol 123:73–87

    Article  PubMed  Google Scholar 

  18. Haarmann T, Lorenz N, Tudzynski P (2008) Use of a nonhomologous end joining deficient strain (Δku70) of the ergot fungus Claviceps purpurea for identification of a nonribosomal peptide synthetase gene involved in ergotamine biosynthesis. Fungal Genet Biol 45:35–44

    Article  CAS  PubMed  Google Scholar 

  19. Lorenz N, Haarmann T, Pažoutová S, Jung M, Tudzynski P (2009) The ergot alkaloid gene cluster : functional analyses and evolutionary aspects. Phytochemistry 70:1822–1832

    Article  CAS  PubMed  Google Scholar 

  20. Hicks C, Witte TE, Sproule A, Lee T, Shoukouhi P, Popovic Z, Menzies JG, Boddy CN, Liu M, Overy DP (2021) Evolution of the ergot alkaloid biosynthetic gene cluster results in divergent mycotoxin profiles in Claviceps purpurea sclerotia. Toxins (Basel) 13:861

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by JSPS KAKENHI Grant Number 16K07238.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomoo Hosoe.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest. The funders had no role in the design of the research.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Doi, Y., Wakana, D., Kitaoka, S. et al. Ergot alkaloids in sclerotia collected in Japan: synthetic profiles and induction of apoptosis by Clavine-type compounds. J Nat Med 77, 306–314 (2023). https://doi.org/10.1007/s11418-022-01673-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11418-022-01673-8

Keywords

Navigation